TWiV 1012: Clinical update with Dr. Daniel Griffin
Episode description
In his weekly clinical update, Dr. Griffin discusses the potential for recurrent Mpox outbreaks among gay, bisexual, and other men who have sex with men, association between SARS-CoV-2 variants and frequency of acute symptoms, prospective study of key correlates for household transmission of SARS-CoV-2, Pfizer's PAXLOVID™ receiving FDA approval for adult patients at high risk of progression to severe COVID-19, efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19, development of a definition of postacute sequelae of SARS-CoV-2 infection, COVID-19 and risk for mental disorders among adults in Denmark, risk of new post-COVID mental disorders higher only in older patients.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Potential for recurrent Mpox outbreaks among men who have sex with men (CDC)
- Association between SARS-CoV-2 variants and frequency of acute symptoms (OFID)
- Key correlates for household transmission of SARS-CoV-2 (OFID)
- PAXLOVID receiving FDA approval for patients at high risk of severe COVID-19 (Pfizer)
- Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients with COVID-19 (The Lancet)
- Development of a definition of postacute sequelae of SARS-CoV-2 (JAMA)
- COVID-19 and risk for mental disorders among adults in Denmark (JAMA)
- Risk of new post-COVID mental disorders higher only in older patients (CIDRAP)
- Contribute to our FIMRC fundraiser at PWB
- Letters read on TWiV 1012
- Dr. Griffin's COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv